Unknown gonadotoxicity chemotherapy and preservation of fertility: Example of Temozolomide;Chimiothérapie à gonadotoxicité inconnue et préservation de la fertilité : exemple du témozolomide

Gynecologie Obstetrique et Fertilite

Volumn 38, Issue 11, 2010, Pages 660-662

  Sitruk, L Sitbon ^a   Sanson, M ^a   Prades, M ^a   Lefebvre, G ^a   Schubert, B ^a   Poirot, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Female fertility; Ovarian function; Preservation of fertility; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; CRYOPRESERVATION; DELIVERY; DRUG EFFECT; EMBRYO; FEMALE; FEMALE FERTILITY; GLIOMA; GONADAL DISEASE; HUMAN; IDIOPATHIC DISEASE; OOCYTE; PREGNANCY; REPRODUCTIVE TOXICITY; SPONTANEOUS ABORTION;

EID: 78649443417     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2010.09.002     Document Type: Article

References (4)

1. D. Meirow, and D. Nugent The effects of radiotherapy and chemotherapy on female reproduction Human Reprod Update 7 2001 535 543
2. K. Oktay, and M. Sönmezer Chemotherapy and amenorrhea: risks and treatment options Curr Opin Obstet Gynecol 20 4 2008 408 415
3. Vidal 2010. Témodal-Témozolomide.
4. C. Palmieri, C. Brock, and E.S. Newlands Maintenance of fertility following treatment with Temozolomide for a high grade astrocytoma J Neurooncol 73 2 2005 185